Hand Eczema Treatment

First-Line Treatment

The American Academy of Dermatology recommends high-potency topical corticosteroids as the most effective first-line treatment for hand eczema, with clobetasol propionate being the preferred option for severe cases requiring rapid control 1
For mild-to-moderate hand eczema, low to moderate potency (class 5-7) topical corticosteroids can be applied twice daily for 1-2 weeks 1
Moderate to high potency (class 3-4) topical corticosteroids can be applied twice daily for up to 2 weeks 1

Urea 10% cream can be applied three times daily to improve skin barrier function in patients with hand eczema 2
Moisturizers should be applied frequently throughout the day, especially after washing hands, and can be used immediately after corticosteroid application or 15-30 minutes before/after 1, 3
Emollients or moisturizers should be applied frequently throughout the day, choosing fragrance-free, preservative-free formulations 1, 3

For severe cases of hand eczema that limit activities of daily living, high-potency topical corticosteroids can be applied twice daily for up to 2 weeks (not exceeding 50g per week) 2
Topical antibiotics in an alcohol-free formulation should be added for at least 14 days if infection is suspected 3
Topical antifungal creams can be used if a fungal infection is suspected 4

For recalcitrant cases of hand eczema, consider phototherapy, systemic therapy, or occupational modification 1
Topical calcineurin inhibitors can be considered as a steroid-sparing approach for patients with hand eczema 1, 5, 6
Sedating antihistamines can be used short-term during relapses with severe itching 7

Proactive, intermittent application (twice weekly) of topical corticosteroids can be used for maintenance therapy to prevent relapses in recurrent conditions 6
Referral to dermatology for patch testing should be considered if no improvement is seen after 2 weeks of appropriate treatment 8, 1
The American Academy of Dermatology recommends consulting a dermatologist if no significant improvement is seen after 7 more days of adjusted treatment 1

Infants under 6 months are more vulnerable to topical treatments and are at increased risk of HPA axis suppression compared to older children 9
A thin layer of topical treatment should be applied to the affected area, without occlusion, to minimize increased absorption 9
High-potency steroids should be avoided on the face due to increased risk of skin atrophy, perioral dermatitis, and rosacea 10, 6
Low potency formulations should be used in sensitive skin areas, such as the face, neck, and skin folds, to minimize the risk of skin atrophy 5